Bartonellosis / Cat scratch disease (Bartonella henselae)

Bartonellosis is a bacterial infection caused primarily by Bartonella henselae, with cats serving as the main reservoir host for this zoonotic pathogen. While commonly known as cat scratch disease in the context of human infection, the disease in cats themselves is referred to as feline bartonellosis. This infection is remarkably prevalent in the feline population, with studies showing that anywhere from 5 to over 40 percent of cats may be infected depending on geographic location and population characteristics. Cats of all breeds and backgrounds can become infected, though those with flea exposure face significantly higher risk.

The infection is transmitted between cats primarily through flea feces, with Ctenocephalides felis (the cat flea) serving as the principal vector. When infected fleas defecate on a cat's skin, the bacteria-laden feces can enter the bloodstream through flea bite wounds, scratches, or grooming activities. Once inside the cat, Bartonella organisms invade red blood cells and endothelial cells lining blood vessels, establishing a persistent infection that can last for months to years. The bacteria have evolved sophisticated mechanisms to evade the feline immune system, allowing them to persist even in immunocompetent cats.

Most infected cats remain clinically healthy despite harboring the bacteria in their bloodstream, a state known as asymptomatic bacteremia. This silent carrier status is significant from a public health perspective, as apparently healthy cats can transmit the infection to humans through scratches or bites that introduce flea feces or cat saliva into wounds. When clinical disease does occur in cats, it may manifest as fever, lethargy, lymph node enlargement, and various inflammatory conditions affecting the eyes, heart, or other organs. Immunocompromised cats typically experience more severe disease manifestations.

Treatment of symptomatic feline bartonellosis involves antibiotic therapy, though complete elimination of the organism proves challenging due to its intracellular location and ability to persist in reservoir sites. The decision to treat asymptomatic carrier cats remains controversial, as antibiotics may suppress but not eliminate infection, and treated cats can become reinfected. Prevention through rigorous flea control represents the most effective strategy for reducing both feline infection rates and zoonotic transmission risk. Veterinary consultation is essential for diagnosis, treatment decisions, and guidance on minimizing transmission risks to human family members.

The primary cause of feline bartonellosis is infection with bacteria of the Bartonella genus, with Bartonella henselae being the most common species affecting cats worldwide. Other Bartonella species, including Bartonella clarridgeiae, Bartonella koehlerae, and Bartonella quintana, can also infect cats, though less frequently. These gram-negative bacteria are highly adapted to survival within mammalian hosts, specifically targeting red blood cells and the cells lining blood vessels. The bacteria's ability to invade and persist within host cells protects them from many immune responses and contributes to the chronic nature of infection.

Genetic and hereditary factors do not directly cause bartonellosis, as susceptibility to infection depends on exposure rather than genetic predisposition. However, the genetic makeup of individual cats may influence their immune response to infection and whether they develop clinical disease or remain asymptomatic carriers. Cats with inherited or acquired immunodeficiencies, such as those infected with feline immunodeficiency virus or feline leukemia virus, may experience more severe disease manifestations. There is no evidence that specific cat breeds carry genetic susceptibility to Bartonella infection.

Environmental and lifestyle factors play crucial roles in Bartonella exposure and transmission. Flea infestation represents the most important risk factor, as fleas serve as the primary vector for transmission between cats. Cats living in warm, humid climates where flea populations thrive year-round face continuous exposure risk. Multi-cat households and environments such as shelters or catteries with high cat density facilitate flea transmission and bacterial spread. Outdoor access exposes cats to feral cat populations with high infection rates and abundant flea populations. Poor flea control practices directly correlate with increased bartonellosis prevalence in cat populations.

Several specific risk factors increase the likelihood of Bartonella infection in individual cats. Kittens and young cats under one year of age have higher infection rates than adult cats, possibly due to increased play behavior that facilitates flea feces inoculation through scratches. Stray, feral, and shelter cats typically show higher prevalence than owned cats with veterinary care. Cats in southern or temperate climates with extended flea seasons face greater cumulative exposure. Co-habitation with infected cats, particularly in the presence of fleas, dramatically increases transmission probability. Lack of routine flea prevention is perhaps the single most important modifiable risk factor.

The mechanism of Bartonella infection involves a complex interplay between the vector, bacteria, and host. Infected fleas acquire the bacteria by feeding on bacteremic cats, with the organisms multiplying within the flea's digestive tract. Bacteria are excreted in flea feces, which contaminate the cat's skin and coat. When cats scratch at flea bites or groom themselves, they create small wounds through which bacteria-laden flea feces can enter. Once in the bloodstream, Bartonella organisms quickly invade red blood cells, where they replicate in membrane-bound vacuoles. The bacteria periodically exit blood cells to invade endothelial cells, establishing secondary reservoirs that contribute to persistent infection despite ongoing immune responses.

Early warning signs of clinical bartonellosis in cats are often subtle and may go unnoticed by even attentive owners. Most cats infected with Bartonella remain completely asymptomatic, serving as healthy-appearing carriers for months to years. When early symptoms do develop, they may include mild, transient fever that resolves without intervention. Slightly decreased energy or enthusiasm for normal activities might be observed. Mild enlargement of lymph nodes, particularly those in the head and neck region, may occur but often goes undetected. These early signs typically appear several weeks to months after initial infection, though the incubation period is not precisely defined.

Common symptoms of clinical feline bartonellosis, when they occur, include persistent or intermittent fever, generalized lymph node enlargement (lymphadenopathy), and lethargy. Some cats develop mild anemia due to the bacteria's presence within red blood cells, causing pallor and weakness. Inflammatory eye conditions, particularly uveitis (inflammation inside the eye), occur in a subset of affected cats and may manifest as redness, squinting, cloudiness, or changes in pupil size. Muscle pain and stiffness have been reported, potentially causing changes in gait or reluctance to move. Some cats exhibit neurological abnormalities, including behavioral changes, tremors, or seizures in severe cases.

Behavioral changes associated with bartonellosis reflect both direct effects of infection and general malaise. Infected cats with clinical disease often become less active and spend more time resting or sleeping. Appetite may decrease, leading to weight loss over time if disease persists. Social cats might become withdrawn or seek isolation more than usual. Play behavior typically diminishes, with affected cats showing little interest in toys or interactive activities. Some cats develop increased irritability or sensitivity to handling, possibly due to muscle soreness or general discomfort. Grooming habits may change, with some cats grooming less and developing unkempt coats.

Physical signs observable on examination include palpably enlarged lymph nodes, most commonly those under the jaw, in front of the shoulder, or behind the knee. Fever, when present, may not be detected without veterinary measurement, as cats often do not feel warm to touch. Eye abnormalities visible to owners might include redness, discharge, obvious inflammation, or changes in pupil appearance. Pale gums or inner eyelids may indicate anemia in more severely affected cats. Oral lesions, including gingivitis and stomatitis, have been associated with bartonellosis in some cats. Heart murmurs may develop in cats with endocarditis, a serious complication affecting heart valves.

Symptom progression in clinical bartonellosis varies considerably among affected cats. Some cats experience a single episode of mild illness followed by spontaneous resolution. Others develop chronic or relapsing disease with periods of relative wellness interspersed with symptomatic episodes. Untreated symptomatic cats may continue to experience low-grade symptoms for extended periods. In immunocompromised cats, disease can progress more rapidly and severely, affecting multiple organ systems. Cats with endocarditis may develop progressive heart failure over weeks to months. The unpredictable nature of symptom progression makes monitoring and veterinary consultation important for any cat showing compatible signs.

Emergency symptoms requiring immediate veterinary attention include severe lethargy or collapse, indicating possible severe anemia or cardiovascular compromise. Difficulty breathing or rapid respiratory rate may suggest anemia, heart involvement, or other serious complications. Complete loss of appetite persisting beyond 24 hours requires evaluation. Sudden blindness or severe eye pain indicates serious ocular involvement needing prompt treatment to preserve vision. Seizures, severe disorientation, or inability to walk suggest neurological involvement. Signs of bleeding, such as nosebleeds, blood in urine, or bruising, may indicate severe blood cell abnormalities. High fever accompanied by significant depression warrants emergency assessment and treatment.

Initial veterinary examination for suspected bartonellosis includes comprehensive history-taking and thorough physical assessment. The veterinarian will inquire about the cat's lifestyle, flea prevention practices, exposure to other cats, and any contact with fleas or flea-infested environments. Information about symptoms, their duration, and any fluctuation in severity helps guide diagnostic planning. Physical examination focuses on lymph node evaluation, cardiac auscultation for murmurs, ophthalmic examination for signs of uveitis, assessment of mucous membrane color, and general body condition evaluation. The presence of fleas or flea dirt during examination supports exposure history.

Diagnostic testing for bartonellosis employs several methodologies with varying sensitivity and specificity. Blood culture specifically designed for Bartonella organisms can detect active bacteremia but requires specialized techniques and extended incubation periods, often taking several weeks for results. Polymerase chain reaction testing detects Bartonella DNA in blood samples with higher sensitivity than standard culture, though results can be affected by intermittent bacteremia. Serologic testing measures antibodies against Bartonella organisms and indicates exposure but cannot distinguish between active infection, past infection, or immune response to recent flea exposure. Complete blood count may reveal anemia and changes in white blood cell populations. Serum biochemistry assesses organ function and overall health status.

Differential diagnosis for bartonellosis includes numerous conditions that produce similar clinical presentations. Other infectious diseases causing fever and lymphadenopathy, such as feline infectious peritonitis, toxoplasmosis, and mycobacterial infections, must be considered. Feline immunodeficiency virus and feline leukemia virus can cause similar symptoms and also predispose to more severe bartonellosis. Lymphoma and other cancers may cause lymph node enlargement mimicking infectious lymphadenopathy. Immune-mediated diseases can produce fever, anemia, and systemic inflammation. Various causes of uveitis, including toxoplasmosis, fungal infections, and neoplasia, should be evaluated in cats with ocular involvement. Accurate differentiation is essential because treatment approaches differ substantially among these conditions.

Diagnosis confirmation often relies on combining multiple test results with clinical findings, as no single test provides definitive diagnosis in all cases. A positive PCR result in a cat with compatible clinical signs strongly supports active infection. Culture isolation of Bartonella organisms provides definitive proof of infection when successful. Serologic testing showing high or rising antibody titers in a symptomatic cat supports the diagnosis. In some cases, presumptive diagnosis is made based on clinical presentation, exclusion of other causes, and response to appropriate antibiotic therapy. Given the high carrier rate in the general cat population, positive test results must be interpreted in context with clinical signs to distinguish incidental infection from disease-causing infection. Veterinary specialists in infectious disease may be consulted for complex cases requiring advanced diagnostic interpretation.

Emergency and immediate treatment for cats with severe bartonellosis manifestations focuses on stabilization and addressing life-threatening complications. Cats with severe anemia may require blood transfusions to restore oxygen-carrying capacity while antibiotic therapy takes effect. Intravenous fluid therapy supports cardiovascular function and addresses dehydration in systemically ill patients. Cats with cardiac involvement from endocarditis require careful fluid management to avoid worsening heart function. Pain management and anti-inflammatory therapy provide comfort for cats with fever, muscle pain, or significant inflammation. Emergency treatment for neurological complications may include anticonvulsant medications and supportive care.

Medical management of symptomatic bartonellosis centers on prolonged antibiotic therapy. Azithromycin has become a first-line treatment option due to good efficacy, convenient dosing schedule, and favorable side effect profile in cats. Doxycycline represents another commonly used antibiotic with documented activity against Bartonella organisms. Treatment duration typically extends for four to six weeks, though some protocols recommend even longer courses to address persistent infection. Rifampin may be added in combination therapy for severe or refractory cases. Despite treatment, complete bacterial elimination is difficult to achieve, and some cats remain carriers after clinical resolution. Monitoring during treatment includes assessment of clinical response and follow-up testing when indicated.

Surgical intervention is not a primary treatment modality for bartonellosis but may be necessary for specific complications. Cats with endocarditis affecting heart valves may occasionally require surgical consultation, though medical management is typically attempted first. Severely enlarged or abscessed lymph nodes might require drainage or biopsy for diagnostic or therapeutic purposes. Eye surgery may be needed in cats with severe ocular complications, such as glaucoma secondary to uveitis. These surgical interventions address complications rather than the underlying infection and are performed in conjunction with medical management.

Supportive care enhances recovery and maintains quality of life during treatment. Nutritional support ensures adequate caloric and nutrient intake, with appetite stimulants or assisted feeding provided as needed. Comfortable resting environments reduce stress and support immune function. Cats with uveitis require topical eye medications to reduce inflammation and prevent complications. Pain management through appropriate analgesics improves comfort and encourages normal behaviors. Regular monitoring during treatment allows early detection of complications or treatment failure.

Alternative and complementary approaches to bartonellosis management have limited evidence but may provide adjunctive support. Probiotics may help maintain gastrointestinal health during prolonged antibiotic therapy. Nutritional supplements supporting immune function are sometimes recommended, though their specific efficacy against Bartonella is unproven. Some integrative veterinary practitioners incorporate acupuncture or herbal therapies alongside conventional treatment. These approaches should complement rather than replace proven antibiotic therapy and should be discussed with the treating veterinarian.

Treatment decision factors for feline bartonellosis include several important considerations. Symptomatic cats clearly benefit from treatment, but the decision to treat asymptomatic carrier cats remains controversial and individualized. Factors influencing treatment decisions include the cat's overall health, presence of immunocompromised humans in the household, severity of clinical signs, and likelihood of treatment success. Cost considerations include diagnostic testing, medications, and follow-up evaluations over an extended treatment period. Owners should understand that treatment may not eliminate carrier status and that reinfection is possible without rigorous flea control. Zoonotic risk management, including flea prevention and safe handling practices, is discussed regardless of whether antibiotic treatment is pursued.

Recovery timeline for cats with clinical bartonellosis varies based on disease severity and specific manifestations. Cats with mild symptoms often show improvement within one to two weeks of starting antibiotic therapy. Fever typically resolves within the first week of treatment in responsive cases. Lymph node enlargement may take several weeks to fully resolve, with gradual reduction observed during treatment. Ocular manifestations may require extended treatment periods and careful monitoring to prevent permanent damage. Full clinical recovery may take four to eight weeks, corresponding with recommended antibiotic treatment duration. Some cats experience rapid improvement while others show more gradual response.

Post-treatment care involves continued monitoring and implementation of prevention strategies. Completion of the full prescribed antibiotic course is essential, even if symptoms resolve before treatment ends. Follow-up veterinary examinations assess treatment response and check for relapse. Repeat testing may be recommended to evaluate bacterial clearance, though interpretation of results can be complex. Implementing rigorous flea prevention for the treated cat and all household pets prevents reinfection. Environmental flea control treats the home to eliminate residual flea populations. Monitoring for symptom recurrence in the weeks and months following treatment completion helps identify potential relapse early.

Prognosis factors for feline bartonellosis depend on multiple variables. Cats with mild clinical disease and prompt treatment typically have excellent prognosis for symptom resolution. Cats with severe manifestations, particularly endocarditis or neurological involvement, face more guarded prognosis. Immunocompromised cats may experience treatment failure or relapse more frequently than immunocompetent cats. The ability to control flea exposure affects long-term outlook significantly. Co-infections with other pathogens may complicate recovery and worsen prognosis. Complete bacterial clearance is difficult to achieve, meaning many cats remain carriers despite clinical improvement.

Long-term outlook for cats recovering from clinical bartonellosis is generally favorable for quality of life, though carrier status may persist. Most cats return to normal activity levels and behavior after successful treatment. Residual effects from complications, such as permanent vision changes from severe uveitis, may occur in some cases. Chronic carrier status means ongoing potential for zoonotic transmission, necessitating continued preventive measures. Reinfection can occur if flea control lapses, particularly in multi-cat households or environments with ongoing flea pressure. Regular veterinary monitoring helps maintain overall health and detect any disease recurrence. With appropriate management, most cats with bartonellosis history enjoy normal lifespans and quality of life.

Primary prevention of feline bartonellosis focuses on interrupting the flea-mediated transmission cycle through comprehensive flea control. Year-round flea prevention using veterinarian-recommended products is the cornerstone of prevention strategy. Effective flea preventives for cats include topical spot-on treatments, oral medications, and flea collars containing appropriate active ingredients. All cats in a household must be treated to prevent flea populations from persisting on untreated animals. Product selection should be made with veterinary guidance, as some flea products are toxic to cats. Consistent, uninterrupted application according to product directions ensures continuous protection.

Environmental prevention strategies address flea populations in the home and outdoor environments. Regular vacuuming of carpets, upholstered furniture, and pet bedding removes flea eggs, larvae, and pupae from the environment. Washing pet bedding in hot water kills all flea life stages. Environmental flea sprays or foggers may be necessary in heavily infested homes. Treating outdoor areas where cats spend time reduces environmental flea populations. Professional pest control services can address severe infestations. Preventing contact with feral or stray cats limits exposure to heavily infected flea populations.

Dietary approaches do not directly prevent Bartonella infection, though nutrition supports overall health and immune function. Complete and balanced nutrition maintains the immune system's ability to respond to infections. Some owners explore garlic or brewer's yeast supplements as natural flea deterrents, though these have limited proven efficacy and garlic may be harmful to cats. Adequate hydration and optimal body condition support general health. No specific dietary interventions have proven ability to prevent bartonellosis transmission.

Health maintenance practices complement flea control in bartonellosis prevention. Regular veterinary wellness examinations provide opportunities to assess flea control compliance and overall health. Keeping cats indoors reduces exposure to environmental flea populations and infected cats. Maintaining good hygiene when handling cats, including prompt wound cleaning after scratches or bites, reduces zoonotic transmission risk. Regular grooming and coat inspection help detect flea infestations early. Treating new cats entering a household with flea prevention before introduction protects resident cats.

Early intervention strategies minimize disease impact when infection occurs. Awareness of bartonellosis symptoms enables prompt veterinary consultation when signs develop. Testing cats with suggestive symptoms allows early diagnosis and treatment initiation. In households with immunocompromised individuals, testing cats for Bartonella carrier status may be recommended to inform risk management decisions. Promptly treating any flea infestations that occur despite preventive measures limits transmission opportunities. Working with a veterinarian to develop comprehensive flea prevention plans tailored to household circumstances provides optimal protection against bartonellosis and other flea-transmitted diseases.

Daily management for cats with bartonellosis, whether recovering from clinical disease or identified as carriers, involves attention to both medical needs and transmission prevention. During active treatment, medication administration follows the prescribed schedule, typically once or twice daily depending on the antibiotic used. Monitoring appetite, energy level, and general behavior provides information about treatment response. Daily flea prevention ensures that even if the cat remains bacteremic, transmission to other cats is interrupted. Observing for any new symptoms or worsening of existing signs guides decisions about veterinary consultation. Once treatment concludes, daily management focuses on prevention and monitoring.

Home environment considerations address both cat welfare and zoonotic transmission risk. Rigorous flea control throughout the home eliminates the vector necessary for transmission between cats. Regular cleaning, including vacuuming and washing pet bedding, removes flea life stages from the environment. Keeping cats indoors or limiting outdoor access reduces exposure to environmental flea populations. Dedicated areas for cat food, water, and rest minimize environmental contamination. Hand washing after handling cats, particularly before eating or touching face, reduces human infection risk. Properly covering and cleaning any scratches or bites immediately reduces zoonotic transmission probability.

Quality of life for cats with bartonellosis is typically excellent, as most infected cats remain asymptomatic. Cats recovering from clinical disease usually return to normal activity levels and enjoyment of life. Regular play, environmental enrichment, and social interaction should continue as the cat's health allows. Maintaining established routines provides comfort and stability. Most cats with bartonellosis history can engage in all normal feline activities once clinical disease resolves. Any permanent effects from complications, such as vision changes, may require environmental modifications for safety.

Ongoing monitoring and care involves attention to potential disease recurrence and overall health maintenance. Awareness of bartonellosis symptoms allows recognition of possible relapse. Regular veterinary examinations, typically annually for healthy adult cats, assess ongoing health. Follow-up testing may occasionally be recommended to evaluate bacterial status, particularly in households with immunocompromised individuals. Consistent flea prevention remains essential indefinitely to prevent reinfection. Reporting new symptoms promptly to the veterinarian enables early intervention if problems develop.

Caregiver support resources help owners manage the unique challenges of bartonellosis. Understanding the zoonotic nature of the disease and implementing appropriate precautions protects human family members while maintaining the human-animal bond. Veterinary staff can answer questions about transmission risk and prevention strategies. Educational materials from veterinary organizations provide reliable information. Immunocompromised individuals should consult their physicians about specific precautions when living with cats. Support groups and online communities connect owners facing similar challenges. Mental health support may benefit owners experiencing anxiety about zoonotic disease risk, helping them implement reasonable precautions while maintaining healthy relationships with their cats.

Bartonellosis does not demonstrate significant breed predisposition in cats, as infection risk relates primarily to flea exposure rather than genetic factors. All cat breeds face equivalent susceptibility to Bartonella infection when exposed to infected fleas. Purebred and mixed-breed cats show similar infection rates when lifestyle factors are comparable. Studies examining bartonellosis prevalence have not identified consistent breed associations that suggest genetic susceptibility differences. The high prevalence of infection across diverse cat populations supports the conclusion that environmental exposure, not genetics, determines infection risk.

Certain cat populations show increased bartonellosis prevalence based on lifestyle characteristics that correlate with flea exposure. Stray and feral cats typically have the highest infection rates due to limited or no flea control and frequent contact with other infected cats. Shelter cats often show elevated prevalence reflecting their origins in high-risk populations. Cats with outdoor access encounter more fleas and infected cats than strictly indoor cats. Kittens and young cats show higher infection rates than adults, possibly due to behaviors that increase flea feces inoculation. Cats in warm, humid climates with year-round flea activity face continuous exposure. These population differences reflect environmental factors rather than breed-related susceptibility.

Screening recommendations for bartonellosis are based on risk factors and household circumstances rather than breed status. Routine screening of healthy cats is generally not recommended due to the high prevalence of asymptomatic carriers and limitations of available tests. Testing may be appropriate for cats with clinical signs compatible with bartonellosis. Households containing immunocompromised individuals may consider testing cats to inform risk management decisions, though test interpretation is complex. Newly adopted cats entering households with immunocompromised members might benefit from screening. Regardless of test results, comprehensive flea control remains the primary prevention strategy. Veterinarians can guide testing decisions based on individual household circumstances and risk tolerance.

Several conditions commonly co-occur or share associations with bartonellosis in cats. Flea infestation itself causes problems beyond Bartonella transmission, including flea allergy dermatitis, anemia from blood loss in heavily parasitized cats, and transmission of other pathogens. Feline immunodeficiency virus and feline leukemia virus frequently coexist with bartonellosis and may worsen disease severity. Hemotropic mycoplasmosis, another flea-transmitted blood cell infection, may occur alongside bartonellosis. Cats with chronic gingivostomatitis have been found to have higher bartonellosis prevalence, suggesting possible association. Co-infections require identification of all pathogens and comprehensive treatment approaches addressing each condition.

Conditions with similar symptoms to bartonellosis require differentiation during diagnostic evaluation. Feline infectious peritonitis can cause fever, lymphadenopathy, and uveitis similar to bartonellosis. Toxoplasmosis produces ocular inflammation and systemic illness that may mimic bartonella infection. Lymphoma causes lymph node enlargement that can resemble infectious lymphadenopathy. Immune-mediated diseases produce fever and inflammatory changes overlapping with bartonellosis presentation. Endocarditis from other bacterial causes may appear identical to bartonella endocarditis. Thorough diagnostic evaluation distinguishes between these conditions and guides appropriate treatment selection.

Potential complications from bartonellosis affect various organ systems and can cause lasting effects. Uveitis may lead to glaucoma, lens luxation, or vision loss if inadequately treated. Endocarditis damages heart valves and can result in progressive heart failure. Neurological involvement may cause persistent deficits in severely affected cats. Chronic inflammation can affect kidneys, liver, and other organs over time. Secondary infections may develop in immunocompromised cats. Prevention of complications relies on early diagnosis, appropriate treatment, and careful monitoring. The zoonotic potential of bartonellosis represents a unique complication, as infected cats can transmit disease to humans through scratches or bites, requiring attention to household risk management alongside treatment of the cat.